Additionally, MALAT1, MEG3, SNHG5, and HOTAIR have also been reported to modulate imatinib-induced apoptosis in CML cells [5,9–11]. The gene discussed is MEG3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.